Mevis Medical Solutions AG
XMUN:M3V
Mevis Medical Solutions AG
XMUN:M3V
Price:
26
EUR
Market Cap:
€47.3m
Balance Sheet
Balance Sheet Decomposition
Mevis Medical Solutions AG
Mevis Medical Solutions AG
Balance Sheet Decomposition is not available for
Mevis Medical Solutions AG
Mevis Medical Solutions AG
Balance Sheet
Mevis Medical Solutions AG
Mevis Medical Solutions AG
Currency: EUR
| Sep-2016 | Sep-2017 | Sep-2018 | Sep-2019 | Sep-2020 | Sep-2021 | Sep-2022 | Sep-2023 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
24
|
30
|
3
|
3
|
4
|
8
|
9
|
8
|
7
|
|
| Cash |
24
|
30
|
3
|
3
|
4
|
8
|
9
|
8
|
7
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
2
|
4
|
4
|
4
|
7
|
3
|
5
|
3
|
3
|
|
| Accounts Receivables |
2
|
4
|
3
|
2
|
3
|
2
|
4
|
3
|
2
|
|
| Other Receivables |
0
|
0
|
1
|
2
|
4
|
1
|
1
|
1
|
1
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
27
|
33
|
7
|
7
|
11
|
11
|
15
|
11
|
10
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
1
|
2
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
|
| Intangible Assets |
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Goodwill |
11
|
11
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
1
|
2
|
16
|
16
|
16
|
16
|
16
|
16
|
16
|
|
| Long-Term Investments |
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
11
|
11
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
43
N/A
|
49
+14%
|
24
-51%
|
24
0%
|
28
+16%
|
28
-1%
|
31
+13%
|
28
-10%
|
26
-6%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
4
|
9
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
4
|
5
|
3
|
4
|
7
|
6
|
9
|
7
|
6
|
|
| Total Current Liabilities |
10
|
16
|
3
|
4
|
8
|
7
|
10
|
7
|
6
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
3
|
2
|
2
|
3
|
4
|
3
|
2
|
|
| Total Liabilities |
10
N/A
|
17
+64%
|
6
-63%
|
6
-1%
|
10
+64%
|
10
-3%
|
13
+38%
|
10
-24%
|
9
-15%
|
|
| Equity | ||||||||||
| Common Stock |
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Retained Earnings |
23
|
23
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
|
| Additional Paid In Capital |
8
|
7
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
33
N/A
|
33
-1%
|
18
-45%
|
18
N/A
|
18
N/A
|
18
N/A
|
18
N/A
|
18
N/A
|
18
N/A
|
|
| Total Liabilities & Equity |
43
N/A
|
49
+14%
|
24
-51%
|
24
0%
|
28
+16%
|
28
-1%
|
31
+13%
|
28
-10%
|
26
-6%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
Switch to:
Switch to:
See Also
Discover More
